There were 156 companies in cities associated with Orange County that received 160 FDA inspections in 2023, according to the U.S. Food and Drug Association.
Assemblymember Diane Dixon has named Marcia Manker as her Woman of the Year for Assembly District 72 in Newport Beach. Manker, the current CEO of MemorialCare Saddleback Medical Center and Orange Coast Center, is being recognized for her leadership in revolutionizing women's healthcare in South Orange County."I am thrilled to make Marcia Manker my 2024 Woman of the Year," said Dixon. "Not only is she leading a hospital that is on the cutting edge of women's health, but she believes in mentoring women in her organization to help them reach their goals. She embodies...
Of the 3,182,923 citizens living in Orange County in 2021, 78% were old enough to vote, equating to 2,483,232 individuals, according to U.S. Census Bureau data obtained on Oct. 26.
Irvine, Calif., March 21, 2024 – A University of California, Irvine-led study has revealed groundbreaking insights into the origins of birth defects, offering new possibilities for early detection and prevention strategies.Published in the journal Science Advances, the study identified key genetic interactions during early embryonic development that shed light on birth defects like Cornelia de Lange syndrome. Co-author Stephenson Chea highlighted the significance of the findings, stating, “Our data suggest that Nipbl and Nanog are more than just necessary players in early...
SACRAMENTO – Assemblymember Diane Dixon (R-Newport Beach) introduced Assembly Bill 1931, Kayleigh’s Law, which aims to provide lifetime injunctions for victims of heinous crimes. The bill is named after Kayleigh Kozak, who successfully advocated for a similar law in Arizona in 2021, and Kristy von Waldburg, an Orange County native and childhood sexual abuse survivor who collaborated with Kayleigh to push for the law in California."After meeting with Kristy it became clear and compelling that we needed to provide a voice for survivors and further protections in the law,"...
A research team led by the University of California, Irvine has identified the critical role played by the APOBEC3A and APOBEC3B enzymes in driving cancer mutations by altering DNA in tumor genomes. The findings offer new possibilities for intervention strategies in cancer treatment.Corresponding author Rémi Buisson, UCI assistant professor of biological chemistry, emphasized the importance of understanding how cancer cells accumulate mutations that contribute to disease progression and drug resistance. Buisson stated, "Both APOBEC3A and APOBEC3B were known to generate...